The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
PROGNOSIS OF PATIENTS WITH LYMPH NODE POSITIVE PROSTATE CANCER FOLLOWING RADICAL PROSTATECTOMY: LONG-TERM RESULTS
Abstract
PURPOSE: We determined the prognostic factors that affect recurrence and survival in patients with lymph node positive prostate cancer. MATERIALS AND METHODS: Between 1972 and 1999, 1,936 patients underwent radical retropubic prostatectomy and pelvic lymph node dissection for clinically organ confined prostate cancer. A total of 235 patients (12.1%) were found to have disease metastatic to the lymph nodes (stage D1). Of the patients 69% received no adjuvant treatment. We reviewed the tumor stage (TNM), Gleason score, number and percent of involved lymph nodes (lymph node density), preoperative prostate specific antigen when available and adjuvant treatment. Overall survival and recurrence-free survival were estimated using Kaplan-Meier plots. RESULTS: Followup was 1 to 24 years (median 11.4). Overall median survival was 15 years. Overall clinical recurrence-free survival at 5, 10 and 15 years was 80%, 65% and 58%, respectively. Patients who had 1 or 2 positive lymph nodes had a clinical recurrence-free survival of 70% and 73% at 10 years, respectively, vs 49% in those who had 5 or more involved lymph nodes (p = 0.0031). When stratified by lymph node density, patients with a lymph node density of 20% or greater were at higher risk for clinical recurrence compared to those with a density of less than 20% (relative risk = 2.32, p <0.0001). On stratified log rank test only prostate cancer T stage, and the number and percent of positive lymph nodes correlated with recurrence-free and overall survival. CONCLUSIONS: Local tumor bulk and the number/percent of involved lymph nodes significantly affect disease progression and the survival rate. Radical prostatectomy may offer long-term survival in patients who have limited tumor bulk and nodal involvement.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Messing, E. M., Manola, J., Sarosdy, M., Wilding, G., Crawford, E. D., & Trump, D. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912093412401 · Cited by 1,191
Johannsen, M., Gneveckow, U., Eckelt, L., Feussner, A., WaldÖFner, N., Scholz, R., Deger, S., Wust, P., Loening, S. A., & Jordan, A. (2005) · International Journal of Hyperthermia · doi:10.1080/02656730500158360 · Cited by 798
PROSTATE-SPECIFIC ANTIGEN AFTER ANATOMIC RADICAL RETROPUBIC PROSTATECTOMY
Pound, C. R., Partin, A. W., Epstein, J. I., & Walsh, P. C. (1997) · Urologic Clinics of North America · doi:10.1016/s0094-0143(05)70386-4 · Cited by 588
Risk of prostate carcinoma death in patients with lymph node metastasis
Cheng, L., Zincke, H., Blute, M. L., Bergstralh, E. J., Scherer, B., & Bostwick, D. G. (2001) · Cancer · doi:10.1002/1097-0142(20010101)91:1<66::aid-cncr9>3.0.co;2-p · Cited by 363
ANATOMICAL EXTENT OF LYMPH NODE DISSECTION: IMPACT ON MEN WITH CLINICALLY LOCALIZED PROSTATE CANCER
ALLAF, M. E., PALAPATTU, G. S., TROCK, B. J., CARTER, H. B., & WALSH, P. C. (2004) · Journal of Urology · doi:10.1097/01.ju.0000140912.45821.1d · Cited by 338
Bochner, B. H., Herr, H. W., & Reuter, V. E. (2001) · The Journal of Urology · doi:10.1016/s0022-5347(05)65555-3 · Cited by 244
Johannsen, M., Thiesen, B., Jordan, A., Taymoorian, K., Gneveckow, U., Waldöfner, N., Scholz, R., Koch, M., Lein, M., Jung, K., et al. (2005) · The Prostate · doi:10.1002/pros.20213 · Cited by 200
Evaluation of Magnetic Fluid Hyperthermia in a Standard Rat Model of Prostate Cancer
Johannsen, M., Jordan, A., Scholz, R., Koch, M., Lein, M., Değer, S., Roigas, J., Jung, K., & Loening, S. A. (2004) · Journal of Endourology · doi:10.1089/0892779041271715 · Cited by 119
Walsh, P. C., DeWeese, T. L., & Eisenberger, M. A. (2001) · The Journal of Urology · doi:10.1016/s0022-5347(05)65972-1 · Cited by 110
van Andel, G., & Kurth, K. H. (2003) · European Urology · doi:10.1016/s0302-2838(03)00208-2 · Cited by 55
Cited by
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Mohler, J., Bahnson, R. R., Boston, B., Busby, J. E., D'Amico, A., Eastham, J. A., Enke, C. A., George, D., Horwitz, E. M., Huben, R. P., et al. (2010) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2010.0012 · Cited by 897
Messing, E. M., Manola, J., Yao, J., Kiernan, M., Crawford, D., Wilding, G., di'SantAgnese, P. A., & Trump, D. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70700-8 · Cited by 893
Eiber, M., Herrmann, K., Calais, J., Hadaschik, B., Giesel, F. L., Hartenbach, M., Hope, T., Reiter, R., Maurer, T., Weber, W. A., et al. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.198119 · Cited by 626
Pelvic Lymph Node Dissection in Prostate Cancer
Briganti, A., Blute, M. L., Eastham, J. H., Graefen, M., Heidenreich, A., Karnes, J. R., Montorsi, F., & Studer, U. E. (2009) · European Urology · doi:10.1016/j.eururo.2009.03.012 · Cited by 501
Metadata
- Authors
- DANESHMAND, S., QUEK, M. L., STEIN, J. P., LIESKOVSKY, G., CAI, J., PINSKI, J., SKINNER, E. C., & SKINNER, D. G.
- Venue
- Journal of Urology
- Published
- 2004-12
- Volume
- 172
- Issue
- 6 Part 1
- Pages
- 2252-2255
- ISSN
- 0022-5347 (ISSN-L)
- 1527-3792
- OpenAlex
- W2080487345
- Cited by
- 318
- References
- 12
- FWCI
- 13.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: PROGNOSIS OF PATIENTS WITH LYMPH NODE POSITIVE PROSTATE CANCER FOLLOWING RADICAL PROSTATECTOMY: LONG-TERM RESULTS. https://app.cochat.ai/papers/10.1097/01.ju.0000143448.04161.cc
- The paper
- DANESHMAND, S., QUEK, M. L., STEIN, J. P., LIESKOVSKY, G., CAI, J., PINSKI, J., SKINNER, E. C., & SKINNER, D. G. (2004). PROGNOSIS OF PATIENTS WITH LYMPH NODE POSITIVE PROSTATE CANCER FOLLOWING RADICAL PROSTATECTOMY: LONG-TERM RESULTS. Journal of Urology. https://doi.org/10.1097/01.ju.0000143448.04161.cc
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.